T

Theriva Biologics
D

TOVX

0.23490
USD
0.01
(2.44%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
0
حجم السوق
10,780,188
المقالات
المزيد

العنوان: Theriva Biologics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.